Filana Therapeutics, Inc. (FLNA)
0.8975
-0.03
(-3.39%)
USD |
NASDAQ |
Aug 31, 16:00
0.91
+0.01
(+1.39%)
After-Hours: 20:00
Filana Therapeutics Free Cash Flow : -29.30M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -29.30M |
| March 31, 2026 | -30.38M |
| December 31, 2025 | -32.83M |
| September 30, 2025 | -83.91M |
| June 30, 2025 | -95.92M |
| March 31, 2025 | -109.24M |
| December 31, 2024 | -117.03M |
| September 30, 2024 | -78.07M |
| June 30, 2024 | -86.31M |
| March 31, 2024 | -87.95M |
| December 31, 2023 | -82.44M |
| September 30, 2023 | -81.07M |
| June 30, 2023 | -77.22M |
| March 31, 2023 | -69.88M |
| December 31, 2022 | -80.23M |
| September 30, 2022 | -67.33M |
| June 30, 2022 | -81.43M |
| March 31, 2022 | -74.06M |
| December 31, 2021 | -52.41M |
| September 30, 2021 | -45.50M |
| June 30, 2021 | -10.86M |
| March 31, 2021 | -6.494M |
| December 31, 2020 | -5.382M |
| September 30, 2020 | -4.796M |
| June 30, 2020 | -3.355M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.104M |
| December 31, 2019 | -2.532M |
| September 30, 2019 | -2.508M |
| June 30, 2019 | -3.214M |
| March 31, 2019 | -3.749M |
| December 31, 2018 | -4.77M |
| September 30, 2018 | -5.642M |
| June 30, 2018 | -6.357M |
| March 31, 2018 | -8.428M |
| December 31, 2017 | -8.237M |
| September 30, 2017 | -9.83M |
| June 30, 2017 | -10.54M |
| March 31, 2017 | -10.62M |
| December 31, 2016 | -12.31M |
| September 30, 2016 | -12.83M |
| June 30, 2016 | -12.37M |
| March 31, 2016 | -11.05M |
| December 31, 2015 | -9.248M |
| September 30, 2015 | -8.264M |
| June 30, 2015 | -7.526M |
| March 31, 2015 | -8.169M |
| December 31, 2014 | -9.629M |
| September 30, 2014 | -8.519M |
| June 30, 2014 | -8.666M |
| March 31, 2014 | -7.876M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CorMedix, Inc. | 250.11M |
| Eloxx Pharmaceuticals, Inc. | -- |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | -0.0066M |
| BioStem Technologies, Inc. | -8.832M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.855M |
| Cash from Investing (Quarterly) | -0.021M |
| Cash from Financing (Quarterly) | -0.016M |
| Free Cash Flow Per Share (Quarterly) | -0.0802 |
| Free Cash Flow to Equity (Quarterly) | -3.876M |
| Free Cash Flow to Firm (Quarterly) | -3.876M |
| Free Cash Flow Yield | -67.59% |